Lbp Am Sa Invests $7.48 Million in Axon Enterprise, Inc. (NASDAQ:AXON)

LBP AM SA bought a new position in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund bought 12,593 shares of the biotechnology company's stock, valued at approximately $7,484,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Asset Dedication LLC grew its stake in Axon Enterprise by 11.3% during the 4th quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company's stock worth $106,000 after purchasing an additional 18 shares in the last quarter. Bleakley Financial Group LLC boosted its position in shares of Axon Enterprise by 1.3% during the 4th quarter. Bleakley Financial Group LLC now owns 1,527 shares of the biotechnology company's stock worth $908,000 after acquiring an additional 20 shares in the last quarter. Venturi Wealth Management LLC boosted its position in shares of Axon Enterprise by 2.7% during the 4th quarter. Venturi Wealth Management LLC now owns 802 shares of the biotechnology company's stock worth $477,000 after acquiring an additional 21 shares in the last quarter. Insigneo Advisory Services LLC boosted its position in shares of Axon Enterprise by 1.4% during the 3rd quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company's stock worth $627,000 after acquiring an additional 22 shares in the last quarter. Finally, Menard Financial Group LLC boosted its position in shares of Axon Enterprise by 0.8% during the 3rd quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company's stock worth $1,204,000 after acquiring an additional 24 shares in the last quarter. 79.08% of the stock is owned by institutional investors and hedge funds.

Remove Ads

Analysts Set New Price Targets

Several research firms have recently issued reports on AXON. Morgan Stanley raised Axon Enterprise from an "equal weight" rating to an "overweight" rating and upped their price objective for the stock from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Barclays reissued a "hold" rating on shares of Axon Enterprise in a report on Monday, March 10th. Needham & Company LLC reissued a "buy" rating and issued a $600.00 target price on shares of Axon Enterprise in a report on Wednesday, February 26th. TD Cowen began coverage on Axon Enterprise in a report on Wednesday, January 8th. They issued a "buy" rating and a $700.00 target price for the company. Finally, The Goldman Sachs Group boosted their target price on Axon Enterprise from $500.00 to $700.00 and gave the company a "buy" rating in a report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have issued a buy rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $604.67.

Insider Buying and Selling at Axon Enterprise

In other news, insider Jeffrey C. Kunins sold 1,035 shares of the stock in a transaction that occurred on Monday, December 23rd. The stock was sold at an average price of $624.47, for a total transaction of $646,326.45. Following the completion of the transaction, the insider now directly owns 124,243 shares of the company's stock, valued at approximately $77,586,026.21. This represents a 0.83 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Jeri Williams sold 307 shares of the stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the transaction, the director now directly owns 1,627 shares of the company's stock, valued at approximately $899,275.44. This trade represents a 15.87 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 1,792 shares of company stock valued at $1,087,843 in the last ninety days. Insiders own 5.70% of the company's stock.

Axon Enterprise Stock Performance

AXON traded up $28.12 on Wednesday, hitting $568.11. 575,938 shares of the company traded hands, compared to its average volume of 852,249. The company has a 50 day moving average of $592.66 and a 200-day moving average of $539.27. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The stock has a market capitalization of $43.53 billion, a PE ratio of 146.80, a PEG ratio of 5.17 and a beta of 1.12. Axon Enterprise, Inc. has a 12-month low of $273.52 and a 12-month high of $715.99.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.